Regeneron Pharmaceuticals (NASDAQ: REGN) recently announced overwhelmingly positive results from a late-stage study of its antibody cocktail therapy in treating individuals infected with COVID-19. In this Motley Fool Live video recorded on March 24, 2021, Motley Fool contributors Keith Speights and Brian Orelli discuss whether or not Regeneron’s therapy could be as important as vaccines in the fight against COVID-19.
Could Regeneron’s Antibody Therapy Be as Important as Vaccines in Fighting COVID?
Latest from Blog
ARK Investment Management and its CEO, Cathie Wood, are two of the hottest names in the…
Brookfield Renewable (NYSE: BEP)(NYSE: BEPC) has agreed to sell its onshore wind operations in the U.K. and…
Shares of paint maker PPG Industries (NYSE: PPG) rose roughly 12% out of the gate on…
Image source: The Motley Fool. HDFC Bank Limited (NYSE: HDB)Q4 2021 Earnings CallApr 17, 2021, 8:00 a.m. ET…
Shares of better-burger company Shake Shack (NYSE: SHAK) have already hit all-time highs earlier in 2021.…